mazindol has been researched along with Asthenia in 1 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
Asthenia: Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruera, E | 1 |
| MacDonald, RN | 1 |
1 other study available for mazindol and Asthenia
| Article | Year |
|---|---|
Overwhelming fatigue in advanced cancer.
Topics: Asthenia; Humans; Mazindol; Methylphenidate; Methylprednisolone; Neoplasms | 1988 |